key: cord-0842621-hvda1b7x
authors: Sarkar, Arkaniva; Agarwal, Rushali; Bandyopadhyay, Boudhayan
title: Molecular docking studies of phytochemicals from Terminalia chebula for identification of potential multi-target inhibitors of SARS-CoV-2 proteins
date: 2022-02-16
journal: J Ayurveda Integr Med
DOI: 10.1016/j.jaim.2022.100557
sha: 8a45d6e6981e943bfff5917de0a0ed7981c8a240
doc_id: 842621
cord_uid: hvda1b7x
The COVID-19 caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged as a global pandemic claiming more than 1.8 million deaths worldwide and no medicine has still been developed till date which is proved to have 100% efficiency in combating against this deadly disease. Terminalia chebula (T. chebula) is known to have antibacterial, antifungal, antiviral, antioxidant, anti-inflammatory properties. In this study, we performed blind docking studies on fifteen phytochemicals from T. chebula to identify potential candidate against the proteins of SARS-CoV-2. Our docking results combined with analysis of Atomic Contact Energy (ACE) data identified 1,3,6-Trigalloyl glucose (-332.14 ± 55.74 kcal/mol), Beta-Sitosterol (-324.75 ± 36.98 kcal/mol) and Daucosterol (-335.67 ± 104.79 kcal/mol) as the most promising candidates which exhibit significantly high inhibition efficiency against all eight SARS-CoV-2 protein targets and these three can be used as potential multi-target drug in treatment and prevention of COVID-19. We believe that our study has the potential to help the scientific communities to develop the multi-target drug from T. chebula to combat against the deadly pathogen SARS-COV-2 in future with the support of extensive wet lab analysis.
The global outbreak of pandemic COVID-19 caused by Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demands the design and development of effective drugs and vaccines as it has already caused more than 1.8 million deaths worldwide within a year in spite of all types of efforts from scientific and medical communities (WHO, 2021) . Although some of the vaccines are under phase 3 trials and also the vaccination has just started across the world (WHO, 2020) , no specific anti-viral drug are developed till date for the treatment and prevention of COVID-19.
In our study, our focus is on the Indian traditional herbal medicine known as "Ayurvedic medicine" as it is completely natural, derived from the plants. In ancient Vedic era, the ayurvedic medicine was regularly used for the treatment of fever, flu, cough and cold . Among all ayurvedic medicines, we mainly focussed on Terminalia chebula as it is known to possess high therapeutic benefits in the treatment of wide range of diseases. It was also regarded as "King of Medicines" because of its efficacy in wide range of traditional remedies and curing several diseases . T. chebula is mainly found in south Asiatic countries and belongs to Terminalia genus which has 250 species distributed across the tropical region of the world . It is reported that some compounds extracted from T. chebula exhibits anti-bacterial and anti-viral activity . In a recent study, Upadhyay et al. performed CoV-2 targeting its main protease to identify the potential therapeutic medicinal herb and found that Tea (C. sinensis) and Haritaki (T. chebula) exhibits significant inhibitory activity against 3CL pro protease of SARS-CoV-2 . This finding led us to perform the in silico screening of phytochemicals from T. chebula to identify the potential drug for the treatment and prevention of COVID-19.
In T. chebula, a wide range of natural products is found which includes several flavonoids, flavins, terpenoids, tannins, steroids, phenols . In the present work, we chose fifteen phytochemical molecules from flavonoids, flavins, terpenoids, steroids families (Table 1) for our screening purpose, and performed blind docking between the selected phytochemicals and the reported crystal structures of the target proteins of SARS-COV-2 having important functions. The target proteins include nucleocapsid protein N-terminal RNA binding domain , NSP15 Endoribonuclease (Kim et al., 2020) , Nsp9 RNA binding protein (Sutton et al., 2004) , Papain-like protease (Shin et al., 2020) , Nonstructural protein 10 (NSP10) , NSP13 helicase , main protease and RNA-dependent RNA polymerase (RdRp) . We analysed for potential inhibitory activity through docking study for all fifteen phytochemicals and found that 1,3,6-Trigalloyl glucose, Beta-Sitosterol and Daucosterol possess most promising inhibitory effect against all eight SARS-CoV-2 proteins.
Arjunetin, Arjungenin, Arjunic acid and Arjunolic acid were also found to be effective against at least six proteins. This result suggested that these phytochemicals can be used as potential multi-target inhibitors against various proteins of SARS-CoV-2, however clinical trials should be conducted to validate this result. obtained from NCBI PubChem database (https://pubchem.ncbi.nlm.nih.gov/) and were categorised based on the class. The ligands were converted into PDB file format using openbabel software (http://openbabel.org).
The quality of the three-dimensional structures of the proteins were validated using Prosa (https://prosa.services.came.sbg.ac.at/prosa.php) and Procheck (https://servicesn.mbi.ucla.edu/PROCHECK/) server. The Z-score and percentage of residues in favoured regions and in outliers were noted for each protein.
J o u r n a l P r e -p r o o f Potential drug binding pockets, volume and surface to volume ratio of the pockets, drugScore and details of residues present in each pocket are identified using DOGSiteScorer server (https://proteins.plus/). The geometric and physicochemical properties of the binding pockets are analyzed and the druggability is estimated with aid of a support vector machine (SVM).
Top three binding pockets are selected based on their drugscore.
Molecular docking was done with the set of 15 ligands to find possible interactions. Patch dock web server (https://bioinfo3d.cs.tau.ac.il/PatchDock/), which works on the basis of shape complementarity approach of molecular docking, was used to perform the docking runs. We opted for blind approach throughout all docking interactions in which there will not be any flexibility in the target proteins and the binding pocket will not be defined, in order to ensure that all the interactions are completely unbiased. The PDB files of the proteins and the ligands were uploaded in place of receptor molecule and ligand molecule respectively. The clustering RMSD was set to 4.0 and the complex type was given as protein-small ligand. Top 100 docked complexes for each protein along with their score, atomic contact energy (ACE) and transformation data were saved. Discovery studio visualizer was used to analyze presence of possible protein-ligand interactions.
The pharmacokinetic properties of major small molecules were predicted with the help of SwissADME server (http://www.swissadme.ch/) and pharmacodynamic properties were .
A library of fifteen phytochemicals of T. chebula was constructed using literature survey (Table 1) . Their 3D structures were retrieved from NCBI PubChem database and categorized based on their functional groups. ADME/T analysis was performed to predict both pharmacokinetic (Table 5 13.1) and pharmacodynamic properties (Table 5 13.2). The eight proteins of SARS-CoV-2 were selected based on their biological functions. The crystal structures of these proteins were retrieved from Protein Data Bank (Table 2 ) and the structural integrity were checked for each PDB file (Table 3 ). The Z-scores and the percentage of residues in favoured region for each protein suggest that they are structurally good for further in silico analysis. The binding pocket for each protein structures were predicted with the help of DOGSiteScorer server and top three major binding pockets were selected for analysis and comparison of the interacting residues in the docking sites (Table 4) .
Each protein was blindly docked against the library of fifteen ligands and top 100 docked complexes for each protein were generated along with docking score and atomic contact energy (ACE) data. The best docking pose was selected based on docking score, favourable ACE and intermolecular interaction. The details of molecular interactions between each protein target and the ligands are discussed below.
J o u r n a l P r e -p r o o f
The nucleocapsid protein plays a crucial role in transcription and translation of viral RNA. It helps formation of ribonucleoproteins during viral assembly, assists in viral RNA synthesis and affects host cell responses .
NSP9 is involved in viral RNA synthesis and mediates viral replication (Sutton et al., 2004) .
Although the RNA binding mechanism is not clearly known, it is important for the virulence
Gly105) which is responsible for its dimerization .
This type of interaction is indicative of possible non-competitive inhibition against the NSP9 activity.
The papain-like protease is responsible for processing viral polyproteins and viral replication.
It is also known to regulate SARS-CoV-2 viral spread and innate immunity (Shin et al., 2020
NSP10 is a small stimulatory and scaffolding protein which stimulates exoribonuclease activity and plays a key role in RNA methylation machinery . NSP10
consists of two zinc binding sites, one with residues Cys74, Cys77, Cys90, and His83, which stabilizes the α2 and α3 helices, and the other with four cysteine residues, Cys117, Cys120, Cys128, Cys130, which stabilizes the C-terminal of the NSP10 protein (Fig. 6E, 6A , 6F, 6D and 6C respectively). All J o u r n a l P r e -p r o o f those molecules are found to bind to a region 16.39±8.1 Å apart from the active site of NSP13 indicating non-competitive type of inhibition.
The main protease plays a key role in mediating viral transcription and replication . This is considered as one of the most important enzymes of SARS CoV 2 and used as primary drug target in several studies .
The RNA-dependent RNA polymerase (RdRp) NSP12 catalyses synthesis of viral RNA with the help of two cofactors NSP7 and NSP8, playing a crucial role in viral replication and transcription . Our docking study against the crystal structure of NSP12 (PDB ID: 6M71) based on ACE data revealed that Arjunetin is the best inhibitor (-404.57 kcal/mol) against NSP12 (Supplementary Table 8 Table 8 12). In case of Arjungenin, Arjunic acid, Arjunolic acid and Beta-Sitosterol, the nature of interaction is completely hydrophobic as evident from the 2D interaction plot (Fig. 8C, 8D , 8E and 8F respectively) and Supplementary . Binding of these molecules to this domain may hinder the formation of polyprotein complex and also disturb the connectivity between the functional domains.
Overall, based on the ACE data (Fig 9) Similar to Beta-Sitosterol, Daucosterol also interacts through its hydrophobic steroid rings ( Fig. 1-8F ). Due to this reason, the interactions in these two cases are highly hydrophobic in nature. In addition to that, Daucosterol involves in H-bonding through its hydroxyl group of glucose ring (Fig. 1-8H) . Arjunetin, Arjungenin, Arjunic acid and Arjunolic acid belong to Triterpenoid category. Structural analysis of docking poses of these compounds indicates that these molecules interact through its six fused aliphatic hexagonal carbon rings which are completely hydrophobic in nature ( Fig. 1-8 B-E respectively) . These compounds are also involved in H-bonding through their exposed hydroxyl groups and carboxylic groups. In case of Arjunetin, it possesses glycosyl group in addition to Triterpenoid moiety, which actively involves in H-bonding ( Fig. 1-8B) . It was observed that the docking interactions of these above-mentioned ligands are primarily hydrophobic in nature which suggests that these ligands readily access the hydrophobic groove of the target proteins through their hydrophobic groups. Because of these highly favourable hydrophobic interactions, the ACE becomes highly negative which confirms the irreversible spontaneous nature of interaction.
In general, galloyl glucose molecules are known for their anti-cancer and anti-diabetic activities . To the best of our knowledge, there is no report on antiviral activity of 1,3,6-Trigalloyl glucose, however, it is known to protect the bone marrow-derived mesenchymal stem cells (bmMSCs) against erastin-induced ferroptosis . In this study, for the first time, 1,3,6-Trigalloyl glucose is identified as antiviral multi-target drug.
Beta-Sitosterol is known to exhibit immune-modulating, anti-inflammatory, anti-ulcer, antidiabetic, and anti-cancer activities . Beta-Sitosterol exhibits antiviral activity against fowlpox and herpes viruses which suggested that it is having the potential to be the antiviral drug. Lin el al. reported that Beta-Sitosterol exhibits inhibitory effect (IC50: 1210 μM) on proteolytic activity of the SARS-CoV 3CL pro as evident from the cell-based assay (Lin et al., 2005) .
Daucosterol is reported to exhibit anti-cancer activities . It is reported that Daucosterol acts as neuroprotective agent against Oxygen-Glucose Deprivation/Reperfusion-mediated injury and reduces somatic cell loss and apoptotic rate . Although there is no clear report on antiviral activity of Daucosterol, the antiviral application of daucosterol and sitosterol is patented in CN201310488412.XA .
Arjunetin is known to possess anti-diabetic activity through inhibition of alpha-amylase accelerator . A recent report on molecular docking studies showed that arjunetin binds to the SARS-CoV-2 protease (3CL, PL and RdRP) and exhibit higher binding affinity compared to that of FDA approved protease inhibitor drugs Lopinavir and Remdesivir, which supports our claim on arjunetin as potential multi-target drug against SARS-CoV-2 proteins .
Arjunic acid and Arjunolic acid exhibit anti-inflammatory property by reducing Nitric Oxide production . In a recent report, Arjunic Acid is identified as potential inhibitors of SARS-CoV-2 (Mpro) using docking studies of saponins and tannins , which supports our finding, however, in our study it is found to be a potential multi-target drug against of SARS-CoV-2 proteins. Although there is a report on inhibitory effects of Arjunolic acid from Cochlospermum tinctorium on Epstein-Barr virus activation , there is no clear conventional report on antiviral activity of this phytochemical against SARS-CoV-2 proteins. In a recent report, Sherif et.al. studied the antiviral activity of 26 active polyphenolic compounds of Rhus spp. against SARS-CoV-2 main protease enzyme (M pro ; 6LU7) using molecular docking approach and identified six polyphenolic compounds as potential inhibitors based on drug likeness, solubility in water, and synthetic accessibility score (SAS) analysis . These polyphenols mainly interact through H-bonding, whereas, in our study, 1,3,6-Trigalloyl glucose, Beta-Sitosterol and Daucosterol interact primarily through hydrophobic residues along with H-bonding.
In place of administering one type of drug, the combination of two or three phytochemicals can be tried in this type of treatment, which requires further wet-lab experimental validation.
Side of effect of these components also have to be analysed in vivo, although there is no notable side effect of T. chebula reported yet except diarrhea in some patients when J o u r n a l P r e -p r o o f administered in excess . Although extensive wetlab experimental validation both in vitro and in vivo is required in future to make it applicable in reality, our study provides the insight into the application of phytochemicals from T. chebula in the treatment and prevention of COVID-19 which can help the scientific and health care communities further to develop effective drugs from plants.
In our study, we investigated the potential of various types of phytochemicals which can be extracted from T. chebula and can be used as multi-target inhibitors against many functional proteins of SARS-CoV-2. Ayurvedic or herbal medicine have been in practice for thousands of years and still is used in treatment of a wide variety of disorders using naturally derived products. This motivated us to explore the field of ayurvedic medicines in order to find multitarget inhibitors for SARS-CoV-2 and we found T. chebula to be our answer, which has both antibacterial and antiviral properties.
Using computational analysis, we observed that 1,3,6-Trigalloyl glucose, Beta-Sitosterol and Daucosterol possess the most promising potential as effective inhibitors against all eight proteins of SARS-CoV-2. Apart from these; Arjunetin, Arjungenin, Arjunic acid and Arjunolic acid also exhibited promising inhibitory effect against six proteins out of the eight.
Although 1,3,6-Trigalloyl glucose and Arjunetin are not having drug likeness properties as per the ADME/T studies, these two can be modified to make it applicable as these are having great potential as effective inhibitors against SARS-CoV-2. The use of naturally derived compounds have their own set of benefits and have a huge potency to be used as antiviral drugs, and hence more research should be done in this domain. Table 5 . ADME/T Properties of the phytochemicals used in this study
Potential of Terminalia Arjuna as a Promising PhytoremedyAgainst COVID-19: DPPH Scavenging, Catalase Inhibition and Molecular Docking Studies
The SARS-coronavirus papainlike protease: structure, function and inhibition by designed antiviral compounds
Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches
Phytochemical Composition, Antioxidant Activity, and Neuroprotective Effect of Terminalia chebula Retzius Extracts. Evidence-Based Complementary and Alternative Medicine
Studies on inhibitors of skin-tumor promotion. Inhibitory effects of triterpenes from Cochlospermum tinctorium on Epstein-Barr virus activation
Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein
Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic
In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (M(pro))
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Daucosterol protects neurons against oxygen-glucose deprivation/reperfusionmediated injury by activating IGF1 signaling pathway
Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors
Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp15 suggests a role for hexamerization as an allosteric switch
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2
Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin
Anti-bacterial and anti-viral activities of extracts from Terminalia chebula barks
Covalent Bridging of Corilagin Improves Antiferroptosis Activity: Comparison with 1,3,6-Tri-O-galloyl-βd-glucopyranose
Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plantderived phenolic compounds
Crystal Structure of the SARS-CoV-2 Non-structural Protein 9
Evaluation of the Anti-Inflammatory Capacity of Beta-Sitosterol in Rodent Assays
Analysis of antioxidative and antiviral biomarkers beta-amyrin, betasitosterol, lupeol, ursolic acid in Guiera senegalensis leaves extract by validated HPTLC methods
Beta sitosterol and Daucosterol (phytosterols identified in Grewia tiliaefolia) perturbs cell cycle and induces apoptotic cell death in A549 cells
Haritaki (Chebulic myrobalan) and its varieties
Terminalia chebula: Review on pharmacological and biochemical studies
Chemical Constituents of Terminalia chebula
Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2
Inhibitory effect of a standardized hydroethanolic extract of Terminalia arjuna bark on alpha-amylase enzyme
Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Synergistic antioxidant activity of plant compositions contained in Chatuphalathika herbal recipe: Terminalia chebula Retz. var. chebula, Terminalia arjuna Wight and Arn
The nsp9 replicase protein of SARS-coronavirus, structure and functional insights
Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease
Ayurvedic Remedies for Covid-19 -A Conceptual Study
Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase
Draft landscape of COVID-19 candidate vaccines: WHO. WHO. (2021). WHO Coronavirus Disease (COVID-19) Dashboard. Retrieved
New antiviral target revealed by the hexameric structure of mouse hepatitis virus nonstructural protein nsp15
Anti-inflammatory activity of constituents isolated from Terminalia chebula
Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose
Potential of Terminalia Arjuna as a Promising PhytoremedyAgainst COVID-19: DPPH Scavenging, Catalase Inhibition and Molecular Docking Studies
The SARS-coronavirus papainlike protease: structure, function and inhibition by designed antiviral compounds
Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches
Phytochemical Composition, Antioxidant Activity, and Neuroprotective Effect of Terminalia chebula Retzius Extracts. Evidence-Based Complementary and Alternative Medicine
Studies on inhibitors of skin-tumor promotion. Inhibitory effects of triterpenes from Cochlospermum tinctorium on Epstein-Barr virus activation
Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein
Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic
In silico investigation of saponins and tannins as potential inhibitors of SARS-CoV-2 main protease (M(pro))
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Daucosterol protects neurons against oxygen-glucose deprivation/reperfusionmediated injury by activating IGF1 signaling pathway
Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors
Crystal structure of a monomeric form of severe acute respiratory syndrome coronavirus endonuclease nsp15 suggests a role for hexamerization as an allosteric switch
Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2
Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin
Anti-bacterial and anti-viral activities of extracts from Terminalia chebula barks
Covalent Bridging of Corilagin Improves Antiferroptosis Activity: Comparison with 1,3,6-Tri-O-galloyl-βd-glucopyranose
Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plantderived phenolic compounds
Crystal Structure of the SARS-CoV-2 Non-structural Protein 9
Evaluation of the Anti-Inflammatory Capacity of Beta-Sitosterol in Rodent Assays
Analysis of antioxidative and antiviral biomarkers beta-amyrin, betasitosterol, lupeol, ursolic acid in Guiera senegalensis leaves extract by validated HPTLC methods
Beta sitosterol and Daucosterol (phytosterols identified in Grewia tiliaefolia) perturbs cell cycle and induces apoptotic cell death in A549 cells
Haritaki (Chebulic myrobalan) and its varieties
Terminalia chebula: Review on pharmacological and biochemical studies
Chemical Constituents of Terminalia chebula
Crystal Structure of Non-Structural Protein 10 from Severe Acute Respiratory Syndrome Coronavirus-2
Inhibitory effect of a standardized hydroethanolic extract of Terminalia arjuna bark on alpha-amylase enzyme
Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
Synergistic antioxidant activity of plant compositions contained in Chatuphalathika herbal recipe: Terminalia chebula Retz. var. chebula, Terminalia arjuna Wight and Arn
The nsp9 replicase protein of SARS-coronavirus, structure and functional insights
Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease
Ayurvedic Remedies for Covid-19 -A Conceptual Study
Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase
Draft landscape of COVID-19 candidate vaccines: WHO. WHO. (2021). WHO Coronavirus Disease (COVID-19) Dashboard. Retrieved
New antiviral target revealed by the hexameric structure of mouse hepatitis virus nonstructural protein nsp15
Anti-inflammatory activity of constituents isolated from Terminalia chebula
Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose
J o u r n a l P r e -p r o o f